EPCAM and lung cancer: In addition, EpCAM is strongly upregulated in primary lung cancer but downregulated in metastatic lung cancer, which can be attributed to the shift of EPCAM promoter hypomethylation in primary lung cancer to EPCAM promoter hypermethylation in metastatic lung cancer [117].